Publication
Enhancing Recurrence-Free Survival Prediction in Hepatocellular Carcinoma: A Time-Updated Model Incorporating Tumor Burden and AFP Dynamics.
dc.contributor.author | Akabane, Miho | |
dc.contributor.author | Kawashima, Jun | |
dc.contributor.author | Altaf, Abdullah | |
dc.contributor.author | Woldesenbet, Selamawit | |
dc.contributor.author | Cauchy, François | |
dc.contributor.author | Aucejo, Federico | |
dc.contributor.author | Popescu, Irinel | |
dc.contributor.author | Kitago, Minoru | |
dc.contributor.author | Martel, Guillaume | |
dc.contributor.author | Ratti, Francesca | |
dc.contributor.author | Aldrighetti, Luca | |
dc.contributor.author | Poultsides, George A | |
dc.contributor.author | Imaoka, Yuki | |
dc.contributor.author | Ruzzenente, Andrea | |
dc.contributor.author | Endo, Itaru | |
dc.contributor.author | Gleisner, Ana | |
dc.contributor.author | Pinto Marques, Hugo | |
dc.contributor.author | Oliveira, Sara | |
dc.contributor.author | Balaia, Jorge | |
dc.contributor.author | Lam, Vincent | |
dc.contributor.author | Hugh, Tom | |
dc.contributor.author | Bhimani, Nazim | |
dc.contributor.author | Shen, Feng | |
dc.contributor.author | Pawlik, Timothy M | |
dc.date.accessioned | 2025-08-28T13:44:50Z | |
dc.date.available | 2025-08-28T13:44:50Z | |
dc.date.issued | 2025-08 | |
dc.description.abstract | Background: Existing models to predict recurrence-free survival (RFS) after hepatectomy for hepatocellular carcinoma (HCC) rely on static preoperative factors such as alpha-fetoprotein (AFP) and tumor burden score (TBS). These models overlook dynamic postoperative AFP changes, which may reflect evolving recurrence risk. We sought to develop a dynamic, real-time model integrating time-updated AFP values with TBS for improved recurrence prediction. Patients and methods: Patients undergoing curative-intent hepatectomy for HCC (2000-2023) were identified from an international, multi-institutional database with RFS as the primary outcome. AFP trajectory was monitored from preoperative to 6- and 12-month postoperative values, using time-varying Cox regression with AFP as a time-dependent covariate. The predictive accuracy of this time-updated model was compared with a static preoperative Cox model excluding postoperative AFP. Results: Among 1911 patients, AFP trajectories differed between recurrent and nonrecurrent cases. While preoperative AFP values were similar, recurrent cases exhibited higher AFP at 6 and 12 months. Multivariable analysis identified TBS (hazard ratio (HR):1.043 [95% confidence interval (CI): 1.002-1.086]; p = 0.039) and postoperative log AFP dynamics (HR:1.216 [CI 1.132-1.305]; p < 0.001) as predictors. Contour plots depicted TBS's influence decreasing over time, while postoperative AFP became more predictive. The time-varying Cox model was created to update RFS predictions continuously on the basis of the latest AFP values. The preoperative Cox model, developed with age, AFP, TBS, and albumin-bilirubin score, had a baseline C-index of 0.61 [0.59-0.63]. At 6 months, the time-varying model's C-index was 0.70 [0.67-0.73] versus 0.59 [0.56-0.61] for the static model; at 12 months, it was 0.70 [0.66-0.73] versus 0.56 [0.53-0.59]. The model was made available online ( https://nm49jf-miho-akabane.shinyapps.io/AFPHCC/ ). Conclusions: Incorporating postoperative AFP dynamics into RFS prediction after HCC resection enhanced prediction accuracy over time, as TBS's influence decreased. This adaptive, time-varying model provides refined RFS predictions throughout follow-up. | eng |
dc.identifier.citation | Ann Surg Oncol . 2025 Aug;32(8):5648-5656. doi: 10.1245/s10434-025-17303-y. | |
dc.identifier.doi | 10.1245/s10434-025-17303-y. | |
dc.identifier.pmid | 40238062 | |
dc.identifier.uri | http://hdl.handle.net/10400.17/5157 | |
dc.language.iso | eng | |
dc.peerreviewed | yes | |
dc.publisher | Springer | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | HCC CIR | |
dc.subject | Aged | |
dc.subject | Female | |
dc.subject | Male | |
dc.subject | Humans | |
dc.subject | Middle Aged | |
dc.subject | Biomarkers | |
dc.subject | Tumor* | |
dc.subject | Carcinoma | |
dc.subject | Hepatocellular* / blood | |
dc.subject | Hepatocellular* / mortality | |
dc.subject | Hepatocellular* / pathology | |
dc.subject | Hepatocellular* / surgery | |
dc.subject | Follow-Up Studies | |
dc.subject | Hepatectomy* / mortality | |
dc.subject | Liver Neoplasms* / blood | |
dc.subject | Liver Neoplasms* / mortality | |
dc.subject | Liver Neoplasms* / pathology | |
dc.subject | Liver Neoplasms* / surgery | |
dc.subject | Neoplasm Recurrence | |
dc.subject | Local* / blood | |
dc.subject | Local* / metabolism | |
dc.subject | Local* / mortality | |
dc.subject | Local* / pathology | |
dc.subject | Local* / surgery | |
dc.subject | Retrospective Studies | |
dc.subject | Prognosis | |
dc.subject | Survival Rate | |
dc.subject | Tumor Burden | |
dc.subject | alpha-Fetoproteins* / metabolism | |
dc.title | Enhancing Recurrence-Free Survival Prediction in Hepatocellular Carcinoma: A Time-Updated Model Incorporating Tumor Burden and AFP Dynamics. | eng |
dc.type | text | |
dspace.entity.type | Publication | |
oaire.citation.endPage | 5656 | |
oaire.citation.issue | 8 | |
oaire.citation.startPage | 5648 | |
oaire.citation.title | Annals of Surgical Oncology | |
oaire.citation.volume | 32 | |
oaire.version | http://purl.org/coar/version/c_970fb48d4fbd8a85 |